LINKS
CONTACT & CONNECT

Headquarters:

19950 W Country Club Drive
7th Floor

Aventura, FL 33180

International Offices:

Germany

info@ipdanalytics.com

+1 (305) 662-8515

  • LinkedIn Social Icon
  • Twitter Social Icon
Asset 211.png

© 2019 by IPD Analytics | Privacy Policy

COMBINING

UNCOMMON EXPERTISE

WITH PROPRIETARY DATA
TO DRIVE UNIQUE INSIGHT 

IPD Analytics identifies, projects, and quantifies the impact of competitive-landscape shifts in the pharmaceutical and biologic market to offer: 

   

 

  • Industry-leading life-cycle analysis

  • Clinical, formulary, procurement, and inventory-control insights for payers, providers, and suppliers

 

  • Brand and generic market impact forecasts

 

  • Pharmaceutical coding and reimbursement information

 

THE INDUSTRY LEADER

AN INDEPENDENT, THIRD-PARTY SOURCE

Since 2002, IPD Analytics has offered solutions that: 

    Deliver compelling insight and unique data assets to solve complex,
    multi-layered problems   

    Enable efficiency and transparency in an opaque pharmaceutical market

    Offer a comprehensive look at the past to help predict future market shifts

We take data from thousands of sources, combine it with proprietary research, and work to normalize, analyze, and summarize... 

With a unique team of experts, including:

 

Former Federal Circuit Patent Clerks and Litigators

Payor and Provider
Clinical Pharmacists

Brand and Generic Financial Forecasters from
Major Manufacturers

PhD Scientists with Pharmacy and Bioscience Backgrounds


Team of Researchers and Patent Searchers Utilizing Proprietary Data Aggregation Tools

We develop the
foundation that powers our solutions:

loss-of-exclusivity

timing

And provide meaningful, tailored insights for
specific use cases:

 

Key Litigation Updates & Analysis

Critical Headlines & 

Day-by-day Trial Updates


Drug & Disease-Class Reviews

 

Formulary Planning Guidance
 

Loss-of-Exclusivity and
Market-Impact Forecasts

Analog Library with Accompanying Qualitative Analysis

Pipeline-Planning Tools
 

Coding & Reimbursement Insights


Drug-Price Tools

Scenario Analysis


We deliver these insights in multiple, easily consumable formats:

To serve stakeholders and institutional investors across the pharmaceutical industry:

Platform

Email Alerts

Direct Consultations

Podcast Episodes

Reports

Data Downloads

Manufacturers:

Brand Manufacturers

Generic Manufacturers

Specialty Drug Manufacturers

Active Ingredient Manufacturers

 

Payors, Providers, & Suppliers:

Payors

Health Systems

Wholesalers

Specialty & Retail Pharmacies

Long-term Care Facilities

IDNs

GPOs

PBMs

Institutional Investors:

Investment Managers

Hedge Funds

Mutual Funds

Sovereign Funds

Pension Funds

 

THE INDUSTRY LEADER

AN INDEPENDENT, THIRD-PARTY SOURCE

Since 2002, IPD Analytics has offered solutions that: 

  • Deliver compelling insight and unique data assets to solve complex, multi-layered problems   

  • Enable efficiency and transparency in an opaque pharmaceutical market

  • Offer a comprehensive look at the past to help predict future market shifts

We take data from thousands of sources, combine it with proprietary research, and work to normalize, analyze, and summarize... 

With a unique team of experts, including:

Former Federal Circuit Clerks, Patent Attorneys, and Litigators

Payor and Provider
Clinical Pharmacists

Brand and Generic Financial Forecasters from
Major Manufacturers

PhD Scientists with Pharmacy and Bioscience Backgrounds


Team of Researchers and Patent Searchers Utilizing Proprietary Data-Aggregation Tools

We develop the
foundation that powers our solutions:

loss-of-exclusivity

timing and innovative, product-launch tracking

And provide meaningful, tailored insights for
specific use cases:

Key Litigation Updates & Analysis

Critical Headlines & 

Day-by-Day Trial Updates


Drug & Disease-Class Reviews

 

Formulary Planning Guidance
 

Loss-of-Exclusivity and
Market-Impact Forecasts

Analog Library with Accompanying Qualitative Analysis

Pipeline-Planning Tools
 

Coding & Reimbursement Insights


Drug-Price Tools

Scenario Analysis


We deliver these insights in multiple, easily consumable formats:

Online Platform

Email Alerts

Phone Consultations

Podcast Episodes

Reports

Data Downloads

To serve stakeholders and institutional investors across the pharmaceutical industry:

Manufacturers:

Brand Manufacturers

Generic Manufacturers

Specialty-Drug Manufacturers

Active-Ingredient Suppliers

 

Payors, Providers, & Suppliers:

Payors

Health Systems

Wholesalers

Specialty & Retail Pharmacies

Long-Term Care Facilities

IDNs

GPOs

PBMs

Institutional Investors:

Investment Managers

Hedge Funds

Mutual Funds

Sovereign Funds

Pension Funds

Private Equity

 

OUR SOLUTIONS

IPD Analytics provides actionable insights to drive decisions.

We offer subscription-based access to our proprietary platform, consultations, real-time email alerts, comprehensive reports, data downloads, podcast episodes, and more.

Pharmaceuticals  |  Biotech  |  Biosimilars

OTHER INDUSTRIES

 

OUR SUBSCRIBERS

IPD Analytics offers tech-enabled solutions to stakeholders across the pharmaceutical landscape.

 
 

PODCAST 

IPD's Drug & Clinical Review:

The Premier Podcast for Drug Intelligence and Management Strategy

Within each episode, IPD's Executive Clinical Pharmacy Team discusses:

  • Drug pipeline intelligence and clinical strategy surrounding loss of exclusivity, high-cost and complex drugs, formulary planning, and pharmacy and therapeutics management

  • Impactful generic, brand, and biosimilar launches coming
    down the pipeline 

 

  • Strategies to improve outcomes, lower pharmacy spend, and optimize formulary design

 

  • Popular questions frequently asked by payers, providers, and manufacturers around the country

Register to listen now!

Already have a password?

NEWSROOM

FEATURED

Press Release

May 9, 2019

The Institute for Clinical and Economic Review (ICER) Will Now Leverage Data and Insights from IPD Analytics

The Institute for Clinical and Economic Review (ICER) has reached an agreement with IPD Analytics, LLC (IPD) whereby ICER will leverage IPD’s data, expertise, and assessments to advance their horizon scanning efforts across the pharmaceutical and biologic markets... See More

INSIGHT BRIEF 

June 5, 2019

Losing by Winning at the Patent Office: Zytiga Case Illustrates How IPR Estoppel Could Reshape Patent Challenges and Delay Generic Launches

What does a recent case decided by the Federal Circuit Court mean for brand and generic manufacturer strategy in the future? Our Insight Brief reveals a subplot with potentially high stakes for payers, providers, and patients alike.

DOWNLOAD NOW

 
 

TALK TO US...

arrow&v
If you'd like to learn more about one or more of our solutions, please specify: